Chemoinformaics analysis of E,E,Z-1,3,12-NONADECATRIENE-5,14-DIOL
| Molecular Weight | 294.479 | nRot | 14 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
| Exact Molecular Weight | 294.256 | nRing | 0 |
| Solubility: LogS | -3.44 | nHRing | 0 |
| Solubility: LogP | 5.019 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 56.005 |
| nHD | 2 | BPOL | 34.109 |
| QED | 0.271 |
| Synth | 3.49 |
| Natural Product Likeliness | 1.891 |
| NR-PPAR-gamma | 0.459 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.162 |
| HIA | 0.114 |
| CACO-2 | -4.752 |
| MDCK | 0.0000265 |
| BBB | 0.874 |
| PPB | 0.950574 |
| VDSS | 1.475 |
| FU | 0.0270716 |
| CYP1A2-inh | 0.133 |
| CYP1A2-sub | 0.422 |
| CYP2c19-inh | 0.119 |
| CYP2c19-sub | 0.433 |
| CYP2c9-inh | 0.15 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.316 |
| CYP3a4-inh | 0.292 |
| CYP3a4-sub | 0.177 |
| CL | 8.132 |
| T12 | 0.265 |
| hERG | 0.009 |
| Ames | 0.139 |
| ROA | 0.064 |
| SkinSen | 0.962 |
| Carcinogencity | 0.567 |
| EI | 0.88 |
| Respiratory | 0.944 |
| NR-Aromatase | 0.381 |
| Antiviral | No |
| Prediction | 0.56646 |